Superbowl bans medical cannabis ad
Superbowl LIV saw Kansas City defeat the San Francisco 49ers. The show attracted 102 million spectators and nearly $400 million in advertising revenue.
And while the booze hounds may have a field day during this extravagant show, some companies still don't have the right to screens.
In 2019, Acreage Holdings was denied airtime by CBS. The company was willing to put up $5 million for its spot, but CBS won't accept advertising for Cannabis, even though Acreage's activities are legal in the countries where it operates.
The main aim of the advert was to encourage the legalization of medical marijuana at federal level.
The ad featured 3 people: a boy who had hundreds of epileptic seizures a day that were not alleviated by traditional treatments, a man addicted to opioids, and a veteran who was in great pain after his leg was amputated.
Everyone attested to the effect of cannabis on their quality of life.
Newsweed takes a look back at this touching commercial.
33 American states have legalized medical cannabis. The federal government has not yet legislated on the subject, but has authorized the sale of’a first cannabis-based medicine, Epidiolex, for people with epilepsy
-
Cannabis and driving2 weeks ago
Cannabis and CBD: French Drivers Can Now Lose Their License Even Without a Positive Test Result
-
Cannabis in France2 weeks ago
Cannabis Legalization: The LFI Bill Has a Major Problem—THC
-
Cannabis in the Netherlands6 days ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in France7 days ago
French medical cannabis remains stalled at the Ministry of Health
-
Business6 days ago
The United Kingdom Is Moving Closer to a Regulated CBD Market
-
Cannabis in Europe2 weeks ago
Andorra Paves the Way for Medical Cannabis Cultivation
-
Cannabis in Argentina3 days ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Cannabis in France3 weeks ago
Drought: Could Hemp Become the New Hope for French Farmers?


You must be logged in to post a comment Login